Metabolic Interventions in Tumor Immunity: Focus on Dual Pathway Inhibitors

Metabolic Interventions in Tumor Immunity: Focus on Dual Pathway Inhibitors

The metabolism of tumors and immune cells in the tumor microenvironment (TME) can affect the fate of cancer and immune responses. Metabolic reprogramming can occur following the activation of metabolic-related signaling pathways, such as phosphoinositide 3-kinases (PI3Ks) and the mammalian target of...

Full description

Bibliographic Details
Main Authors: Min Chen, Huanrong Lan, Shiya Yao, Ketao Jin, Yun Chen
Format: Article
Language:English
Published: MDPI AG 2023-03-01
Series:Cancers
Subjects:
metabolic intervention
dual inhibitor
metabolic reprogramming
cancer therapy
Online Access:https://www.mdpi.com/2072-6694/15/7/2043

Internet

https://www.mdpi.com/2072-6694/15/7/2043

Similar Items